Literature DB >> 7539043

Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.

K W Muszynski1, F W Ruscetti, G Heidecker, U Rapp, J Troppmair, J M Gooya, J R Keller.   

Abstract

Raf-1 is a 74-kD serine/threonine kinase located in the cell cytoplasm that is activated by phosphorylation in cells stimulated with a variety of mitogens and growth factors, including hematopoietic growth factors. Using c-raf antisense oligonucleotides to block Raf-1 expression, we have established that Raf-1 is required for hematopoietic growth factor-induced proliferation of murine cell lines stimulated by growth factors whose receptors are members of several different structural classes: (a) the hematopoietin receptor family, including interleukin (IL)-2, IL-3, IL-4, granulocyte colony-stimulating factor, granulocyte/macrophage colony-stimulating factor (GM-CSF), and erythropoietin; (b) the tyrosine kinase receptor class, including Steel factor and CSF-1; and (c) IL-6, leukemia inhibitory factor, and oncostatin M, whose receptors include the gp130 receptor subunit. Although results of previous experiments had suggested that IL-4 does not phosphorylate or activate the Raf-1 kinase, c-raf antisense oligonucleotides inhibited IL-4-induced proliferation of both myeloid and T cell lines, and IL-4 activated Raf-1 kinase activity in an IL-4-dependent myeloid cell line. In colony assays, c-raf antisense oligonucleotides completely inhibited colony formation of unseparated normal murine bone marrow cells stimulated with either IL-3 or CSF-1 and partially inhibited cells stimulated with GM-CSF. In addition, c-raf antisense oligonucleotides completely inhibited both IL-3- and GM-CSF-induced colony formation of CD34+ purified human progenitors stimulated with these same growth factors. Thus, Raf-1 is required for growth factor-induced proliferation of leukemic murine progenitor cell lines and normal murine and human bone marrow-derived progenitor cells regardless of the growth factor used to stimulate cell growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539043      PMCID: PMC2192061          DOI: 10.1084/jem.181.6.2189

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

1.  A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro.

Authors:  A M Gewirtz; B Calabretta
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

2.  Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1.

Authors:  E R Stanley; A Bartocci; D Patinkin; M Rosendaal; T R Bradley
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Lineage-specific requirement of c-abl function in normal hematopoiesis.

Authors:  D Caracciolo; M Valtieri; D Venturelli; C Peschle; A M Gewirtz; B Calabretta
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

5.  Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity.

Authors:  D K Morrison; D R Kaplan; U Rapp; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase.

Authors:  H G Wang; T Miyashita; S Takayama; T Sato; T Torigoe; S Krajewski; S Tanaka; L Hovey; J Troppmair; U R Rapp
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

7.  A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow.

Authors:  R W Tindle; R A Nichols; L Chan; D Campana; D Catovsky; G D Birnie
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

8.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

9.  Detection of the myristylated gag-raf transforming protein with raf-specific antipeptide sera.

Authors:  A M Schultz; T D Copeland; G E Mark; U R Rapp; S Oroszlan
Journal:  Virology       Date:  1985-10-15       Impact factor: 3.616

10.  Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.

Authors:  R G Andrews; J W Singer; I D Bernstein
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  8 in total

1.  Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen-activated protein kinase signal transduction pathway.

Authors:  K W Muszynski; T Ohashi; C Hanson; S K Ruscetti
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Ral is both necessary and sufficient for the inhibition of myeloid differentiation mediated by Ras.

Authors:  Nader Omidvar; Lorna Pearn; Alan K Burnett; Richard L Darley
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation.

Authors:  David Wan-Cheng Li; Jin-Ping Liu; Ying-Wei Mao; Hua Xiang; Juan Wang; Wei-Ya Ma; Zigang Dong; Helen M Pike; Rhoderick E Brown; John C Reed
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

4.  Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP.

Authors:  K W Muszynski; D Thompson; C Hanson; R Lyons; A Spadaccini; S K Ruscetti
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras.

Authors:  Mandayam O Nandan; Hong S Yoon; Weidong Zhao; Lillian A Ouko; Sengthong Chanchevalap; Vincent W Yang
Journal:  Oncogene       Date:  2004-04-22       Impact factor: 9.867

6.  Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes.

Authors:  H Hida; M Takeda; B Soliven
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

7.  Ubiquitous expression of MAKORIN-2 in normal and malignant hematopoietic cells and its growth promoting activity.

Authors:  King Yiu Lee; Kathy Yuen Yee Chan; Kam Sze Tsang; Yang Chao Chen; Hsiang-fu Kung; Pak Cheung Ng; Chi Kong Li; Kam Tong Leung; Karen Li
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

8.  Lyn, Jak2, and Raf-1 kinases are critical for the antiapoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation.

Authors:  K Pazdrak; B Olszewska-Pazdrak; S Stafford; R P Garofalo; R Alam
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.